Table 1.
The pathways involved in three cases
| Modules | Pathways | Q-value (Q < 0.05) |
|---|---|---|
| GSE48060 | Natural killer cell mediated cytotoxicity | 1.066849e−07 |
| Graft-versus-host disease | 1.956196e−07 | |
| Allograft rejection | 1.237023e−05 | |
| Cytokine-cytokine receptor interaction | 1.231519e−04 | |
| Type I diabetes mellitus | 3.664642e−04 | |
| GSE60993 | Ribosome | 1.315470e−06 |
| Intestinal immune network for IgA production | 8.294981e−05 | |
| Allograft rejection | 1.018873e−04 | |
| Hematopoietic cell lineage | 3.178231e−04 | |
| NF-kappa B signaling pathway | 4.203928e−04 | |
| GSE66360 | Graft-versus-host disease | 7.291560e−18 |
| Natural killer cell mediated cytotoxicity | 1.330539e−15 | |
| Antigen processing and presentation | 1.330539e−15 | |
| Cytokine-cytokine receptor interaction | 3.994169e−01 | |
| Gap junction | 3.994169e−01 |